Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome
Authors:
- 11 March 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 40 (8) , 1133-1137
Abstract
Our aim was to investigate the relationship between plasma interleukin-6 (IL-6) levels with different measures of central obesity among Saudi women with and without polycystic ovarian syndrome (PCOS). One hundred and sixty-four Saudi females, between 22 and 38 years of age, with and without PCOS were enrolled in this case-control study. Physical examination and laboratory tests were completed for every subject. 2/3 of the study population were obese. Fasting serum insulin, plasma IL-6 levels and insulin resistance show significant increase among POCS than the controls (p<.05). Based on linear regression analysis, C-reactive protein (hs-CRP) was the only independent predictor of plasma IL-6 levels, accounting for 4% of the variability in plasma IL-6 (β = 0.217, p=.005, 95% CI: 0.049–0.275). Coexistence of metabolic and inflammatory factors in PCOS females is accompanied by central obesity which overpowers the effect of insulin resistance, contributing to higher plasma levels of IL-6 and CRP.Keywords
This publication has 31 references indexed in Scilit:
- Is PCOS an inflammatory process?Fertility and Sterility, 2012
- No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controlsHuman Reproduction, 2011
- Polycystic ovary syndrome: an ancient disorder?Fertility and Sterility, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatmentClinical Endocrinology, 2009
- Evidence of proatherogenic inflammation in polycystic ovary syndromeMetabolism, 2009
- Abdominal adiposity and the polycystic ovary syndromeTrends in Endocrinology & Metabolism, 2007
- Relationship of Alcohol Intake With Inflammatory Markers and Plasminogen Activator Inhibitior-1 in Well-Functioning Older AdultsCirculation, 2004
- Inflammation and Insulin ResistanceDiabetes Care, 2003
- Insulin Resistance in Nonobese Patients with Polycystic Ovary SyndromeHormone Research in Paediatrics, 2001